.png){kind=logo}
GC Asia
IFFIm gives guidance on groundbreaking debut sukuk
The International Finance Facility for Immunisation (IFFIm) has given initial price thoughts of mid-to-high teens of basis points over three month Libor as it looks to price a debut dollar sukuk.
The Reg S deal will be a three year benchmark-sized floating rate note.
Standard Chartered is acting as global co-ordinator, with Barwa Bank CIMB, National Bank of Abu Dhabi and NCB Capital the other joint bookrunners. Books are open and pricing is expected ...Already a subscriber? Login
-
Latest news from Emerging Markets
-
China policy and markets round-up: Fiscal revenue returns to growth, Sweden bans Huawei, S&P expands to exchange bond market
23 Oct 2020 -
China issuers sneak into closing bond window
23 Oct 2020 -
Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO
23 Oct 2020 -
Vedanta returns loan, redeems bond after failed delisting
23 Oct 2020 -
Lufax launches roadshow for $2.36bn US IPO
23 Oct 2020
-
-
Latest news from Emerging Markets
-
China policy and markets round-up: Fiscal revenue returns to growth, Sweden bans Huawei, S&P expands to exchange bond market
23 Oct 2020 -
China issuers sneak into closing bond window
23 Oct 2020 -
Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO
23 Oct 2020 -
Vedanta returns loan, redeems bond after failed delisting
23 Oct 2020 -
Lufax launches roadshow for $2.36bn US IPO
23 Oct 2020
-
Further Reading
-
People & Markets
China policy and markets round-up: Fiscal revenue returns to growth, Sweden bans Huawei, S&P expands to exchange bond market
-
Corp
China issuers sneak into closing bond window
-
IPOs
Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO
-
Leveraged/non-investment grade
Vedanta returns loan, redeems bond after failed delisting
